In a regulatory filing, Bristol Myers (BMY) disclosed that its Chief Medical Officer Samit Hirawat bought 4,250 shares of common stock on April 25th in a total transaction size of $202K.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers price target lowered to $47 from $56 at HSBC
- Bristol Myers price target lowered to $52 from $54 at UBS
- Bristol Myers price target raised to $56 from $54 at BofA
- Bristol Myers price target lowered to $53 from $62 at Wells Fargo
- Bristol-Myers Squibb: Hold Rating Amidst Strong Q1 Performance and Long-Term Growth Challenges